-transparent.png){kind=logo}
The antitumor effect of recombinant human tumor necrosis factor (rH-TNF) on two clones of rat fibrosarcoma with different metastatic potential to lymph nodes was examined. The colony formation of clone A, which has high metastatic potential, was completely inhibited by continuous exposure to rH-TNF at 50 U/ml. In contrast, colony formation of clone G, which has low metastatic potential, was not inhibited by high concentrations of rH-TNF (10,000 U/ml). The inhibitory effect of rH-TNF on colony formation by clone A was also observed with a 1-h exposure to rH-TNF. This effect was time and concentration dependent, as determined by the colony assay, 3H-thymidine uptake assay, and 51Cr-release assay. 3H-thymidine and 3H-uridine uptake per cell of clone A exposed to rH-TNF was not decreased. This suggests that the mechanisms of the antitumor effect of rH-TNF were not due to inhibition of DNA and RNA synthesis of tumor cells. In vivo growth and lymph node metastases of clone A inoculated i.p. to Donryu strain rats were completely suppressed by 14 consecutive i.p. injections of 10(5) or 10(6) U/kg per day of rH-TNF. On the other hand the growth of clone G was not influenced by rH-TNF administration.
J Ishihara, and
N Saijo, and
Y Sasaki, and
H Nakano, and
A Ozaki, and
H Takahashi, and
M Sakurai, and
K Nakagawa, and
M Iigo, and
F Kanzawa
January 1987,
Lymphokine research,
J Ishihara, and
N Saijo, and
Y Sasaki, and
H Nakano, and
A Ozaki, and
H Takahashi, and
M Sakurai, and
K Nakagawa, and
M Iigo, and
F Kanzawa
September 1994,
Annals of surgical oncology,
J Ishihara, and
N Saijo, and
Y Sasaki, and
H Nakano, and
A Ozaki, and
H Takahashi, and
M Sakurai, and
K Nakagawa, and
M Iigo, and
F Kanzawa
August 1989,
Circulatory shock,
J Ishihara, and
N Saijo, and
Y Sasaki, and
H Nakano, and
A Ozaki, and
H Takahashi, and
M Sakurai, and
K Nakagawa, and
M Iigo, and
F Kanzawa
January 1992,
Acta neuropathologica,
J Ishihara, and
N Saijo, and
Y Sasaki, and
H Nakano, and
A Ozaki, and
H Takahashi, and
M Sakurai, and
K Nakagawa, and
M Iigo, and
F Kanzawa
June 1988,
Journal of immunology (Baltimore, Md. : 1950),
J Ishihara, and
N Saijo, and
Y Sasaki, and
H Nakano, and
A Ozaki, and
H Takahashi, and
M Sakurai, and
K Nakagawa, and
M Iigo, and
F Kanzawa
June 1987,
Laboratory investigation; a journal of technical methods and pathology,
J Ishihara, and
N Saijo, and
Y Sasaki, and
H Nakano, and
A Ozaki, and
H Takahashi, and
M Sakurai, and
K Nakagawa, and
M Iigo, and
F Kanzawa
July 1990,
Cancer research,
J Ishihara, and
N Saijo, and
Y Sasaki, and
H Nakano, and
A Ozaki, and
H Takahashi, and
M Sakurai, and
K Nakagawa, and
M Iigo, and
F Kanzawa
October 1991,
Journal of neurosurgery,
J Ishihara, and
N Saijo, and
Y Sasaki, and
H Nakano, and
A Ozaki, and
H Takahashi, and
M Sakurai, and
K Nakagawa, and
M Iigo, and
F Kanzawa
June 2001,
Biological & pharmaceutical bulletin,
J Ishihara, and
N Saijo, and
Y Sasaki, and
H Nakano, and
A Ozaki, and
H Takahashi, and
M Sakurai, and
K Nakagawa, and
M Iigo, and
F Kanzawa
January 1988,
Lymphokine research,
